BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20093368)

  • 1. p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis.
    Jolly PS; Berkowitz P; Bektas M; Lee HE; Chua M; Diaz LA; Rubenstein DS
    J Biol Chem; 2010 Mar; 285(12):8936-41. PubMed ID: 20093368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies.
    Calkins CC; Setzer SV; Jennings JM; Summers S; Tsunoda K; Amagai M; Kowalczyk AP
    J Biol Chem; 2006 Mar; 281(11):7623-34. PubMed ID: 16377623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism.
    Delva E; Jennings JM; Calkins CC; Kottke MD; Faundez V; Kowalczyk AP
    J Biol Chem; 2008 Jun; 283(26):18303-13. PubMed ID: 18434319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis.
    Bektas M; Jolly PS; Berkowitz P; Amagai M; Rubenstein DS
    J Biol Chem; 2013 Mar; 288(13):9447-56. PubMed ID: 23404504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris.
    Schlögl E; Radeva MY; Vielmuth F; Schinner C; Waschke J; Spindler V
    Front Immunol; 2018; 9():858. PubMed ID: 29922278
    [No Abstract]   [Full Text] [Related]  

  • 6. Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis.
    Lee HE; Berkowitz P; Jolly PS; Diaz LA; Chua MP; Rubenstein DS
    J Biol Chem; 2009 May; 284(18):12524-32. PubMed ID: 19270308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3.
    Jennings JM; Tucker DK; Kottke MD; Saito M; Delva E; Hanakawa Y; Amagai M; Kowalczyk AP
    J Invest Dermatol; 2011 Mar; 131(3):706-18. PubMed ID: 21160493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new ex vivo human oral mucosa model reveals that p38MAPK inhibition is not effective in preventing autoantibody-induced mucosal blistering in pemphigus.
    Egu DT; Sigmund AM; Schmidt E; Spindler V; Walter E; Waschke J
    Br J Dermatol; 2020 Apr; 182(4):987-994. PubMed ID: 31218663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization.
    Berkowitz P; Hu P; Liu Z; Diaz LA; Enghild JJ; Chua MP; Rubenstein DS
    J Biol Chem; 2005 Jun; 280(25):23778-84. PubMed ID: 15840580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris.
    Mao X; Sano Y; Park JM; Payne AS
    J Biol Chem; 2011 Jan; 286(2):1283-91. PubMed ID: 21078676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation.
    Saito M; Stahley SN; Caughman CY; Mao X; Tucker DK; Payne AS; Amagai M; Kowalczyk AP
    PLoS One; 2012; 7(12):e50696. PubMed ID: 23226536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
    Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
    Front Immunol; 2018; 9():1935. PubMed ID: 30233569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plakophilin-1 protects keratinocytes from pemphigus vulgaris IgG by forming calcium-independent desmosomes.
    Tucker DK; Stahley SN; Kowalczyk AP
    J Invest Dermatol; 2014 Apr; 134(4):1033-1043. PubMed ID: 24056861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    FEBS Lett; 2006 May; 580(13):3276-81. PubMed ID: 16698018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Dsg1- and Dsg3-Mediated Signaling in Pemphigus Autoantibody-Induced Loss of Keratinocyte Cohesion.
    Walter E; Vielmuth F; Wanuske MT; Seifert M; Pollmann R; Eming R; Waschke J
    Front Immunol; 2019; 10():1128. PubMed ID: 31178865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of the desmosomal protein perp enhances the phenotypic effects of pemphigus vulgaris autoantibodies.
    Nguyen B; Dusek RL; Beaudry VG; Marinkovich MP; Attardi LD
    J Invest Dermatol; 2009 Jul; 129(7):1710-8. PubMed ID: 19158843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus reverses pemphigus vulgaris serum-induced depletion of desmoglein in HaCaT cells via inhibition of heat shock protein 27 phosphorylation.
    Xie Z; Dai X; Li Q; Lin S; Ye X
    BMC Immunol; 2023 Nov; 24(1):43. PubMed ID: 37940861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus.
    Walter E; Vielmuth F; Rotkopf L; Sárdy M; Horváth ON; Goebeler M; Schmidt E; Eming R; Hertl M; Spindler V; Waschke J
    Sci Rep; 2017 Jun; 7(1):3579. PubMed ID: 28620161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversial role of antibodies against linear epitopes of desmoglein 3 in pemphigus vulgaris, as revealed by semiquantitative living cell immunofluorescence microscopy and in-cell ELISA.
    Lanza A; Perillo L; Landi C; Femiano F; Gombos F; Cirillo N
    Int J Immunopathol Pharmacol; 2010; 23(4):1047-55. PubMed ID: 21244754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.